Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Influence of the Microbiome on NAFLD and NASH.

Literature DB >> 33552480

The Influence of the Microbiome on NAFLD and NASH.

Somaya A M Albhaisi¹, Jasmohan S Bajaj².

Abstract

Watch a video presentation of this article Watch an interview with the author.

Year: 2021 PMID： 33552480 PMCID： PMC7849305 DOI： 10.1002/cld.1010

Source DB: PubMed Journal: Clin Liver Dis (Hoboken) ISSN： 2046-2484

19 in total

1. Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.

Authors: Kento Imajo; Koji Fujita; Masato Yoneda; Yuichi Nozaki; Yuji Ogawa; Yoshiyasu Shinohara; Shingo Kato; Hironori Mawatari; Wataru Shibata; Hiroshi Kitani; Kenichi Ikejima; Hiroyuki Kirikoshi; Noriko Nakajima; Satoru Saito; Shiro Maeyama; Sumio Watanabe; Koichiro Wada; Atsushi Nakajima
Journal: Cell Metab Date: 2012-07-03 Impact factor: 27.287

Review 2. Cooperation of Toll-like receptor signals in innate immune defence.

Authors: Giorgio Trinchieri; Alan Sher
Journal: Nat Rev Immunol Date: 2007-03 Impact factor: 53.106

3. Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats.

Authors: María Úbeda; Margaret Lario; Leticia Muñoz; María-José Borrero; Macarena Rodríguez-Serrano; Ana-María Sánchez-Díaz; Rosa Del Campo; Lourdes Lledó; Óscar Pastor; Laura García-Bermejo; David Díaz; Melchor Álvarez-Mon; Agustín Albillos
Journal: J Hepatol Date: 2015-12-23 Impact factor: 25.083

4. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.

Authors: Rohit Loomba; Victor Seguritan; Weizhong Li; Tao Long; Niels Klitgord; Archana Bhatt; Parambir Singh Dulai; Cyrielle Caussy; Richele Bettencourt; Sarah K Highlander; Marcus B Jones; Claude B Sirlin; Bernd Schnabl; Lauren Brinkac; Nicholas Schork; Chi-Hua Chen; David A Brenner; William Biggs; Shibu Yooseph; J Craig Venter; Karen E Nelson
Journal: Cell Metab Date: 2017-05-02 Impact factor: 27.287

5. FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid.

Authors: Elliot S Friedman; Yun Li; Ting-Chin David Shen; Jack Jiang; Lillian Chau; Luciano Adorini; Farah Babakhani; Jeffrey Edwards; David Shapiro; Chunyu Zhao; Rotonya M Carr; Kyle Bittinger; Hongzhe Li; Gary D Wu
Journal: Gastroenterology Date: 2018-08-23 Impact factor: 22.682

6. Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis.

Authors: A Alisi; G Bedogni; G Baviera; V Giorgio; E Porro; C Paris; P Giammaria; L Reali; F Anania; V Nobili
Journal: Aliment Pharmacol Ther Date: 2014-04-16 Impact factor: 8.171

Review 7. Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.

Authors: Juan P Arab; Saul J Karpen; Paul A Dawson; Marco Arrese; Michael Trauner
Journal: Hepatology Date: 2016-08-04 Impact factor: 17.425

8. A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease.

Authors: Cyrielle Caussy; Anupriya Tripathi; Greg Humphrey; Shirin Bassirian; Seema Singh; Claire Faulkner; Ricki Bettencourt; Emily Rizo; Lisa Richards; Zhenjiang Z Xu; Michael R Downes; Ronald M Evans; David A Brenner; Claude B Sirlin; Rob Knight; Rohit Loomba
Journal: Nat Commun Date: 2019-03-29 Impact factor: 14.919

9. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.

Authors: P D Cani; S Possemiers; T Van de Wiele; Y Guiot; A Everard; O Rottier; L Geurts; D Naslain; A Neyrinck; D M Lambert; G G Muccioli; N M Delzenne
Journal: Gut Date: 2009-02-24 Impact factor: 23.059

10. Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study.

Authors: Vincent Wai-Sun Wong; Chi-Hang Tse; Tommy Tsan-Yuk Lam; Grace Lai-Hung Wong; Angel Mei-Ling Chim; Winnie Chiu-Wing Chu; David Ka-Wai Yeung; Patrick Tik-Wan Law; Hoi-Shan Kwan; Jun Yu; Joseph Jao-Yiu Sung; Henry Lik-Yuen Chan
Journal: PLoS One Date: 2013-04-25 Impact factor: 3.240

6 in total

1. Gallstone Disease and Bacterial Metabolic Performance of Gut Microbiota in Middle-Aged and Older Patients.

Authors: Doina Georgescu; Ioana Ionita; Ana Lascu; Emil-Florin Hut; Simona Dragan; Oana-Elena Ancusa; Mihai Ionita; Despina Calamar-Popovici; Liviu-Andrei Georgescu; Daniel-Florin Lighezan
Journal: Int J Gen Med Date: 2022-06-08

Review 2. Bile Acid Receptors and the Gut-Liver Axis in Nonalcoholic Fatty Liver Disease.

Authors: Rui Xue; Lianyong Su; Shengyi Lai; Yanyan Wang; Derrick Zhao; Jiangao Fan; Weidong Chen; Phillip B Hylemon; Huiping Zhou
Journal: Cells Date: 2021-10-20 Impact factor: 7.666

3. Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome.

Authors: Martha D Gay; Hong Cao; Narayan Shivapurkar; Sivanesan Dakshanamurthy; Bhaskar Kallakury; Robin D Tucker; John Kwagyan; Jill P Smith
Journal: Int J Mol Sci Date: 2022-02-08 Impact factor: 6.208